Quantcast

Latest Anti-thymocyte globulin Stories

2011-08-04 13:01:13

A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival significantly more than did Thymoglobulin, a similar but reportedly more potent treatment. The research was funded by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health; the study participants were treated and then followed at the NIH Clinical Center in...

2011-05-19 13:53:41

In the first head-to-head comparison of the three most common drugs used at the time of a kidney transplant to prevent organ rejection, researchers found that the least expensive drug "“ at one-half to one-fifth the price "“ is as safe and effective as the other two, according to a paper published by University of Alabama at Birmingham researchers in the May 19, 2011, issue of the New England Journal of Medicine. Based at UAB, researchers in the INTAC trial spent three years...

2009-12-05 14:00:00

The methods and outcomes for stem cell transplants are constantly improving as leading experts continue to investigate new approaches for reducing the serious adverse events associated with the procedure. Research presented today at the 51st Annual Meeting of the American Society of Hematology takes a closer look at complications of stem cell transplants, including veno-occlusive disease and graft-versus-host disease. "While stem cell transplant is one of the best treatment options we have...

2009-12-05 14:00:00

NEW ORLEANS, Dec. 5 /PRNewswire/ -- The methods and outcomes for stem cell transplants are constantly improving as leading experts continue to investigate new approaches for reducing the serious adverse events associated with the procedure. Research presented today at the 51st Annual Meeting of the American Society of Hematology takes a closer look at complications of stem cell transplants, including veno-occlusive disease and graft-versus-host disease. "While stem cell transplant is one...

2009-10-14 13:37:56

A newer, less expensive drug used to suppress the immune system and prevent organ rejection in kidney and pancreas transplant patients works just as well as its much more expensive counterpart, according to a new study by researchers at Wake Forest University Baptist Medical Center. Such discoveries are vital in an era of skyrocketing health care costs and debate over health reform, said lead investigator Alan C. Farney, M.D., Ph.D., an associate professor of surgery in the Department of...

2008-11-04 09:00:29

Genzyme Corp. (Nasdaq: GENZ) and Osiris Therapeutics (Nasdaq: OSIR) announced today that they have entered a strategic alliance for the development and commercialization of Prochymal and Chondrogen, two novel, late-stage adult stem cell treatments that hold significant potential to treat a wide range of diseases. These stem-cell products are designed to provide therapeutic benefit by controlling inflammation, promoting tissue regeneration, and preventing scar formation. Under the terms...

2008-10-03 03:00:00

By McKay, Dianne Potter, Steven R; Behrend, Terry; Stella, Frank; Steinberg, Steven The need for deceased donor organs for kidney transplantation in the United States continues to increase. The increasing demand has fueled desperate attempts by patients to circumvent the long waiting list of the United Network for Organ Sharing. We report 4 patients with end-stage kidney disease who sought and obtained a live donor kidney transplant outside the United States. In each case, a nephrologist...

2008-01-23 06:00:54

Reportlinker.com announces that a new market research report related to the Health Care industry is available in its catalogue. Organ Transplant Immunosuppressive Markets To order that report: www.reportlinker.com/p075365/Organ-Transplant- Immunosuppressive-Markets.html (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) For more information, contact Nicolas by email nbo@reportlinker.com ,...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.